Prevail Therapeutics

7 Decision Makers · 7 Verified Contacts & Email Format

📍 New York, NYFinance & Banking🗓 Est. 2017👥 51–100 employees

About Prevail Therapeutics

Prevail Therapeutics is a biotechnology company focused on developing novel gene therapies for patients with Parkinson’s disease.

Email Format

{first_name}.{last_name}@prevailtherapeutics.com — 100.0%

sarah.smith@prevailtherapeutics.com

Leadership & Decision Makers

Contact details of 7 Prevail Therapeutics decision makers

David Litwack

Director of Regulatory Strategy & Communications
  • Work email

    d***********k@prevailtherapeutics.com

Jeremiah Hendricks

Senior Principal Scientist LinkedIn
  • Work email

    j****************s@prevailtherapeutics.com

Li Chin Wong

Associate Director LinkedIn
  • Work email

    l***g@prevailtherapeutics.com

Franz Hefti

CEO

Jeffrey Sevigny

Chief Medical Officer

Yong Dai

Chief Technology Officer

Asa Abeliovich

Founder

General Emails

General company emails, e.g. customer support lines

    info@prevailtherapeutics.com

    General Inquiries

    admin@prevailtherapeutics.com

    Admin Team

    patienten@prevailtherapeutics.com

    Unclassified inbox

    pacientes@prevailtherapeutics.com

    Unclassified inbox

Similar Companies like Prevail Therapeutics

Finance & Banking · New York, NY · Est. 2001 · 11–50 employees

HQ: New York, NY

Blackstone Group

blackstone.com
Finance & Banking · New York, NY · Est. 1985 · 251–500 employees

HQ: New York, NY

Finance & Banking · New York, NY · Est. 1935 · Above 10001 employees

HQ: New York, NY

JPMorgan Partners

jpmorgan.com
Finance & Banking · New York, NY · Est. 1984 · Above 10001 employees · $5M–$10M

HQ: New York, NY

Explore similar firms in the Finance & Banking sector

Company Info

Last updated: 28/07/2025

917-336-9310

New York, NY

Legal Name: Prevail Therapeutics, Inc.,
Employees: 51-100
Founded Date: 2017
Company Type: For Profit
Stock Symbol: NASDAQ:PRVL
Operating Status: Active
Last Funding Type: Series B
Phone Number: 917-336-9310
Last Investment Activity: Jul 18, 2023
Investments Activity: Jul 18, 2023 May 17, 2023 Dec 15, 2020

Our service is undergoing beta testing, and you can get all the information that is closed on this page for free by registering. You will not need to provide your credit/debit card details.